Ke YC - Search Results

1

[Discussion on optimal duration of pegylated interferon α combined with ribavirin for chronic hepatitis C in HIV-infected patients].

Ke YC, Li LH, Hu FY, Lan Y, He YZ, Chen XJ, Tang XP, Cai WP, Lu RC, He Y, Li HQ. Ke YC, et al. Zhonghua Gan Zang Bing Za Zhi. 2018 Apr 20;26(4):282-287. doi: 10.3760/cma.j.issn.1007-3418.2018.04.010. Zhonghua Gan Zang Bing Za Zhi. 2018. PMID: 29996340 Chinese.

2

[Clinical efficacy of pegylated interferon in patients co-infected with HIV and HCV who failed standard interferon therapy].

Ke YC, Li LH, Hu FY, He Y, Lan Y, Chen XJ, Tang XP, Cai WP. Ke YC, et al. Zhonghua Gan Zang Bing Za Zhi. 2016 Mar 20;24(3):181-5. doi: 10.3760/cma.j.issn.1007-3418.2016.03.005. Zhonghua Gan Zang Bing Za Zhi. 2016. PMID: 27095760 Chinese.

3

An improved experimental method for simultaneously isolating hepatocytes and hepatic stellate cells in mouse liver infected with Echinococcus multilocularis.

Bi X, Yang N, Ke Y, Liu H, Ma W, Fang B, Sun L, Li L, Lü G, Lin R. Bi X, et al. J Clin Lab Anal. 2021 Dec;35(12):e24084. doi: 10.1002/jcla.24084. Epub 2021 Nov 1. J Clin Lab Anal. 2021. PMID: 34724252 Free PMC article.

4

Impact of shift work on dementia: a systematic review and dose-response meta-analysis.

Gao Y, Fu X, Hu H, Li T, Yuan L, Zhang J, Wu Y, Wang M, Ke Y, Li X, Hu F, Zhang M, Sun L, Wen H, Guan R, Gao P, Chai W, Zhao Y, Hu D. Gao Y, et al. Public Health. 2023 Oct;223:80-86. doi: 10.1016/j.puhe.2023.07.029. Epub 2023 Aug 23. Public Health. 2023. PMID: 37625271 Review.

5

Serum platelet-derived growth factor-BB levels as a potential biomarker in assessing the metabolic activity of lesions in alveolar echinococcosis patients.

Ke Y, Bi X, Yang N, Chu J, Li X, Ma W, Liu H, Wang H, Li L, Li C, Qin Y, Aji T, Shao Y, Lü G, Lin R. Ke Y, et al. Acta Trop. 2022 Mar;227:106290. doi: 10.1016/j.actatropica.2021.106290. Epub 2021 Dec 22. Acta Trop. 2022. PMID: 34951977

6

Decline of serum HBV DNA and no change apportioned by the same hepatic parenchyma cell volume from hepatic fibrosis stage 1 to stage 4 during the natural history of chronic hepatitis B.

Ke WM, Xie SB, Yu LN, Liu T, Lai J, He DQ, Li XH, Gao ZL, Ke Y, Chen PJ. Ke WM, et al. Intervirology. 2008;51(4):235-40. doi: 10.1159/000156482. Epub 2008 Sep 24. Intervirology. 2008. PMID: 18812696

7

Differentiation Induction of Mesenchymal Stem Cells by a Au Delivery Platform.

Yang MY, Chiu CD, Ke YC, Yang YC, Chang KB, Chen CM, Lee HT, Tang CL, Liu BS, Hung HS. Yang MY, et al. Among authors: ke yc. Cells. 2023 Jul 19;12(14):1893. doi: 10.3390/cells12141893. Cells. 2023. PMID: 37508556 Free PMC article.

8

Early Dysbiosis and Dampened Gut Microbe Oscillation Precede Motor Dysfunction and Neuropathology in Animal Models of Parkinson's Disease.

Liang F, Chen CY, Li YP, Ke YC, Ho EP, Jeng CF, Lin CH, Chen SK. Liang F, et al. Among authors: ke yc. J Parkinsons Dis. 2022;12(8):2423-2440. doi: 10.3233/JPD-223431. J Parkinsons Dis. 2022. PMID: 36155528

9

Tailoring key enzymes for renewable and high-level itaconic acid production using genetic Escherichia coli via whole-cell bioconversion.

Hsiang CC, Diankristanti PA, Tan SI, Ke YC, Chen YC, Effendi SSW, Ng IS. Hsiang CC, et al. Among authors: ke yc. Enzyme Microb Technol. 2022 Oct;160:110087. doi: 10.1016/j.enzmictec.2022.110087. Epub 2022 Jun 24. Enzyme Microb Technol. 2022. PMID: 35797847

10

Development of resveratrol with thiolated alginate as a supplement to prevent nonalcoholic fatty liver disease (NAFLD).

Ke YC, Chen TC, Tang RC, Lin JN, Lin FH. Ke YC, et al. APL Bioeng. 2022 Feb 8;6(1):016102. doi: 10.1063/5.0081695. eCollection 2022 Mar. APL Bioeng. 2022. PMID: 35178496 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

23 results

Search Page

Filters